Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Post: Chemist - Production-Unit-3-JDM

read more

Thomson Reuters is the leading source of intelligent information for the world's businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. Through its more than 50,000 people across 93 countries, Thomson Reuters delivers this must-have insight to the financial, legal, tax and accounting, scientific, healthcare and media markets, and is powered by the world's most trusted news organization.

Post: Associate - Intellectual Property, Life Sciences

read more

Applications are invited on plain paper for filling up of position(s) of Project Assistant(s) II on a purely temporary basis, in the prescribed proforma. The details of the Sponsored Project under which engagement is proposed to be made is as under:

read more

Transfer of erstwhile Progeny Testing Bull Farm Hisar from the Haryana State Government, to the Indian Council of Agricultural Research in the year 1985, paved the way for the establishment of the Central Institute for Research on Buffaloes (CIRB). Available infrastructure, land, assets and buffalo herd of the Progeny Testing Bull Farm were transferred to the CIRB and the Institute started functioning from 1st February 1985 at Hisar. The Institute has approved cadre strength of 40 scientists of which 34 scientists are in position, including at the sub-campus.

Central Institute for Research on Buffaloes, Hisar (Haryana) will conduct walk-in-interview for the purely temporary position of Senior Research Fellow (SRF) on contractual basis as per detail mentioned below.

read more

This setup of University continued till 1998. Since then few more Institutes and Centers were opened to broad base the training programmes of Ayurveda. At present following Institutes and Centers are working in the Campus of Gujarat Ayurveda University, Jamnagar as constituent Institutes:-
Institute for Post Graduate Teaching & Research In Ayurveda, Shri Gulabkunwarba Ayurveda Mahavidyalaya, Jamnagar, Institute for Ayurvedic Pharmaceutical Sciences, Maharishi Patanjali Institute for Yoga & Naturopathy Education and Research.

Post: Principal, Lecturer- PharmaTech I.A.P.S.: Vacant post:01.Category: Gen, Lecturer- Pharmachemistry I.A.P.S.: Vacant post: 01. Category: SEBC

read more

The National Institute of Pharmaceutical Education and Research (NIPER) has been created as a centre of excellence for higher education, research and development in pharmaceutical sciences. NIPER, Rae Bareli at ITI campus, Rae Bareli under the mentoring Institute of Central Drug Research Institute, Lucknow invites eligible candidates for following positions on purely temporary basis on contract initially for a period of 1 year which can be extended further. The selected candidates shall have no claim for regularization against any regular post either in NIPER or CDRI.

read more

The Indian Association for the Cultivation of Science (IACS), founded on July 29, 1876 by Dr Mahendra Lal Sircar, is an autonomous Institute. It is the oldest research institute in India. The institute is devoted to the pursuit of fundamental  research in the frontier areas of  Physics, Chemistry, Biology, Energy, Polymer and Materials. In each field, IACS nurtures young and innovative research fellows in their doctoral programs.

Walk-in-interview for a JRF position will be held on 19.11.2013 at 3.00 P.M. in the C.V. Raman Hall of Indian Association for the Cultivation of Science (IACS).

Post: Junior Research Fellow (JRF)

read more

ABOUT AUTHORS:
Jyotirmoyee Patnaik
Kanak Manjari Institute of pharmaceutical Sciences
Rourkela, Orissa
patnaik.jyotirmoyee@gmail.com

read more

About Authors:
Pathak Namita*, Kothiyal Preeti
Department of Clinical Pharmacy,
Shri Guru Ram Rai Institute of Technology and Sciences,
Dehradun, Uttarakhand, India, 248001
pathak_namita@ymail.com

Abstract
The prevalence of hypothyroidism is three times higher among women than men. The prevalence in an unselect­ed community population of young, middle aged and elderly individuals is about 1.4 percent and the estimated annual incidence rate is one to two per 1,000 women. Surveys of geriatric populations have yielded estimated prevalence rates for overt hypothyroidism of 0.2 percent to 3 percent. The presentation of symptoms in the elderly may be atypical or absent. The prevalence of subclinical hypothyroidism is estimated to be between 4.0–8.5% of the adult US population without known thyroid disease, and the prevalence increases with age. Up to 20% of women over the age of 60 are estimated to have subclinical hypothyroidism. Caucasians are more likely to have subclinical hypothyroidism than non-Caucasians. The risk is highest in those with type I diabetes mellitus, a family history of thyroid disease or head/neck cancers treated with external beam radiation. Other risk factors include previous radioactive iodine treatment or thyroid surgery. Interestingly, about 20% of patients on thyroid medications are both over re­placed and under replaced. Because of the high incidence of thyroid disease, The American Thyroid Association recommends measuring thyroid function on all adults beginning at age 35 years and every 5 years thereafter noting that more frequent screening may be appropriate in high risk groups. The treatment of subclinical hypothyroidism has been controversial but more recent data suggest there are increased risks of ischemic heart disease in untreated patients and that a more aggressive approach to treat­ ment would be appropriate.7 In contrast, subclinical hyperthyroidism has more well understood risks of atrial fibrillation and flutter and so should be more ag­gressively treated.

read more